Filing Details

Accession Number:
0001562180-25-000853
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-03 19:28:43
Reporting Period:
2025-01-30
Filing Date:
2025-02-03
Accepted Time:
2025-02-03 19:28:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831363 Terns Pharmaceuticals Inc. TERN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1962407 Sun Melita Jung C/O Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd., Suite 100
Foster City CA 94404
Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-30 2,250 $5.11 2,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2025-01-30 325,000 $0.00 325,000 $4.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
325,000 2035-01-29 No 4 A Direct
Footnotes
  1. Includes 2,250 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2024.
  2. 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.